Document Type
Article
Publication Date
1-4-2021
Publication Title
Journal of Medical Case Reports
Abstract
Background: To date, there are only a few case reports of cyclophosphamide (Cy)-induced hemorrhagic cystitis (HC) in adult or pediatric allogeneic stem cell transplant (SCT) patients treated successfully with hyperbaric oxygen (HBO). In all the reported cases, Cy was used as a part of the conditioning regimen, rather than post-transplant for graft-versus-host-disease (GVHD) prophylaxis. More recently, the risk of HC in allogeneic SCT is further increased by the widespread use of post-transplantation cyclophosphamide (PTCy) as a highly effective strategy for GVHD prophylaxis. This is the first case reported of PTCy-induced HC successfully treated with HBO to the best of our knowledge.Case Presentation: In this article, we present a 58-year-old Caucasian male case of allogeneic SCT complicated by severe HC following PTCy, which was successfully treated with HBO, eliminating the need for cystectomy.Conclusion: HBO can be a safe, noninvasive, alternative treatment modality for PTCy-induced HC developing in allogeneic SCT patients.
First Page
1
PubMed ID
33397476
Volume
15
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Recommended Citation
Ibrahim, Moayed; Bhyravabhotla, Kshama; Khalaf, Basil; Van Meter, Keith; Saba, Nakhle S; Safah, Hana; and Socola, Francisco, "The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the literature." (2021). School of Medicine Faculty Publications. 684.
https://digitalscholar.lsuhsc.edu/som_facpubs/684
Included in
Emergency Medicine Commons, Female Urogenital Diseases and Pregnancy Complications Commons, Immune System Diseases Commons, Male Urogenital Diseases Commons, Organic Chemicals Commons, Surgical Procedures, Operative Commons, Therapeutics Commons